Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1326535.RAx6nSt_k8iPCqSkvFvbsJmpHMXlEhxTi8A5C3R3-vKRI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1326535.RAx6nSt_k8iPCqSkvFvbsJmpHMXlEhxTi8A5C3R3-vKRI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1326535.RAx6nSt_k8iPCqSkvFvbsJmpHMXlEhxTi8A5C3R3-vKRI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1326535.RAx6nSt_k8iPCqSkvFvbsJmpHMXlEhxTi8A5C3R3-vKRI130_provenance.
- NP1326535.RAx6nSt_k8iPCqSkvFvbsJmpHMXlEhxTi8A5C3R3-vKRI130_assertion description "[Members of the ATP-binding cassette transporter superfamily such as the P-glycoproteins (MDR) and the cystic fibrosis transmembrane conductance regulator (CFTR) share conserved sequence motifs in their nucleotide binding fold that are the major targets for CFTR mutations in patients with cystic fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1326535.RAx6nSt_k8iPCqSkvFvbsJmpHMXlEhxTi8A5C3R3-vKRI130_provenance.
- NP1326535.RAx6nSt_k8iPCqSkvFvbsJmpHMXlEhxTi8A5C3R3-vKRI130_assertion evidence source_evidence_literature NP1326535.RAx6nSt_k8iPCqSkvFvbsJmpHMXlEhxTi8A5C3R3-vKRI130_provenance.
- NP1326535.RAx6nSt_k8iPCqSkvFvbsJmpHMXlEhxTi8A5C3R3-vKRI130_assertion SIO_000772 7914197 NP1326535.RAx6nSt_k8iPCqSkvFvbsJmpHMXlEhxTi8A5C3R3-vKRI130_provenance.
- NP1326535.RAx6nSt_k8iPCqSkvFvbsJmpHMXlEhxTi8A5C3R3-vKRI130_assertion wasDerivedFrom befree-2016 NP1326535.RAx6nSt_k8iPCqSkvFvbsJmpHMXlEhxTi8A5C3R3-vKRI130_provenance.
- NP1326535.RAx6nSt_k8iPCqSkvFvbsJmpHMXlEhxTi8A5C3R3-vKRI130_assertion wasGeneratedBy ECO_0000203 NP1326535.RAx6nSt_k8iPCqSkvFvbsJmpHMXlEhxTi8A5C3R3-vKRI130_provenance.
- befree-2016 importedOn "2016-02-19" NP1326535.RAx6nSt_k8iPCqSkvFvbsJmpHMXlEhxTi8A5C3R3-vKRI130_provenance.